Overview Dividends

(PATH) Uipath - Ratings and Ratios

Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US90364P1057

Automation, Robots, Cloud, AI

PATH EPS (Earnings per Share)

EPS Growth (3Y CAGR): -61.74%
EPS Trend (3Y Correlation): -16.0%

PATH Revenue

Revenue Growth (3Y CAGR): 12.33%
Revenue Trend (3Y Correlation): 73.9%

Description: PATH Uipath November 06, 2025

UiPath Inc. (NYSE:PATH) offers a comprehensive automation platform that combines robotic process automation (RPA) with embedded AI, machine learning, and natural-language processing to let enterprises design end-to-end workflows using low-code, drag-and-drop tools. The solution spans UI automation, API integration, and AI-driven document understanding, and is delivered via a multi-tenant cloud architecture that provides built-in security, governance, and rapid deployment without on-premise infrastructure.

In its most recent fiscal year, UiPath reported revenue of approximately $1.9 billion, representing a year-over-year growth rate of roughly 30%, and an annual recurring revenue (ARR) run-rate near $2.1 billion. The company’s gross margin stayed above 80%, while churn on its subscription base remained under 5%, indicating strong customer retention and pricing power in the high-growth RPA market.

The RPA sector is being propelled by a projected compound annual growth rate of about 20% through 2029, driven by accelerating digital transformation initiatives, rising labor cost pressures, and increasing regulatory compliance demands across financial services, healthcare, manufacturing, retail, and the public sector-all core verticals for UiPath. Additionally, macro-economic trends such as tighter labor markets and the push for AI-augmented productivity are expanding the addressable market for automation platforms.

For a deeper, data-driven assessment of UiPath’s valuation metrics and competitive positioning, you may find ValueRay’s analytical dashboards useful as a next step in your research.

PATH Stock Overview

Market Cap in USD	8,427m
Sub-Industry	Systems Software
IPO / Inception	2021-04-21

PATH Stock Ratings

Growth Rating	-5.70%
Fundamental	48.7%
Dividend Rating	-
Return 12m vs S&P 500	-6.27%
Analyst Rating	3.17 of 5

PATH Dividends

Currently no dividends paid

PATH Growth Ratios

Growth Correlation 3m	89%
Growth Correlation 12m	-13.1%
Growth Correlation 5y	-73%
CAGR 5y	4.43%
CAGR/Max DD 3y (Calmar Ratio)	0.07
CAGR/Mean DD 3y (Pain Ratio)	0.14
Sharpe Ratio 12m	-0.07
Alpha	-4.68
Beta	1.070
Volatility	66.10%
Current Volume	17528k
Average Volume 20d	25832.3k
Stop Loss	13.2 (-7.7%)
Signal	-1.16

Piotroski VR‑10 (Strict, 0-10) 4.0

Net Income (20.2m TTM) > 0 and > 6% of Revenue (6% = 89.8m TTM)

FCFTA 0.12 (>2.0%) and ΔFCFTA -0.15pp (YES ≥ +1.0pp, WARN ≥ +0.5pp)

NWC/Revenue 86.35% (prev 118.8%; Δ -32.41pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp)

CFO/TA 0.13 (>3.0%) and CFO 334.7m > Net Income 20.2m (YES >=105%, WARN >=100%)

NO Net Debt/EBITDA fails (EBITDA <= 0)

Current Ratio 2.75 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active)

Outstanding Shares last Quarter (542.9m) change vs 12m ago -4.43% (target <= -2.0% for YES)

Gross Margin 82.86% (prev 83.85%; Δ -0.99pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0)

Asset Turnover 56.55% (prev 51.18%; Δ 5.37pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0)

Interest Coverage Ratio -0.78 (EBITDA TTM -30.0m / Interest Expense TTM -58.0m) >= 6 (WARN >= 3)

Altman Z'' -1.62

(A) 0.50 = (Total Current Assets 2.03b - Total Current Liabilities 738.4m) / Total Assets 2.59b

(B) -0.77 = Retained Earnings (Balance) -2.01b / Total Assets 2.59b

(D) -2.14 = Book Value of Equity -1.98b / Total Liabilities 926.6m

Total Rating: -1.62 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D)

ValueRay F-Score (Strict, 0-100) 48.70

1. Piotroski 4.0pt = -1.0

2. FCF Yield 4.39% = 2.20

3. FCF Margin 20.69% = 5.17

4. Debt/Equity 0.04 = 2.50

5. Debt/Ebitda 18.53 = -2.50

6. ROIC - WACC (= -11.22)% = -12.50

7. RoE 1.16% = 0.10

8. Rev. Trend 73.86% = 5.54

9. EPS Trend -16.03% = -0.80

What is the price of PATH shares?

As of November 09, 2025, the stock is trading at USD 14.30 with a total of 17,527,979 shares traded.
Over the past week, the price has changed by -9.84%, over one month by -3.51%, over three months by +30.83% and over the past year by +6.88%.

Is Uipath a good stock to buy?

No, based on ValueRay´s Fundamental Analyses, Uipath (NYSE:PATH) is currently (November 2025) a stock to sell. It has a ValueRay Fundamental Rating of 48.70 and therefor a negative outlook according to the companies health.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of PATH is around 13.59 USD . This means that PATH is currently overvalued and has a potential downside of -4.97%.

Is PATH a buy, sell or hold?

Uipath has received a consensus analysts rating of 3.17. Therefor, it is recommend to hold PATH.

Strong Buy: 3
Buy: 1
Hold: 18
Sell: 1
Strong Sell: 1

What are the forecasts/targets for the PATH price?

Issuer	Target	Up/Down from current
Wallstreet Target Price	13.7	-4.1%
Analysts Target Price	13.7	-4.1%
ValueRay Target Price	15.4	7.3%

PATH Fundamental Data Overview November 01, 2025

Market Cap USD = 8.43b (8.43b USD * 1.0 USD.USD)
P/E Trailing = 529.0
P/E Forward = 16.8919
P/S = 5.6308
P/B = 4.0647
P/EG = 0.4825
Beta = 1.07
Revenue TTM = 1.50b USD
EBIT TTM = -45.2m USD
EBITDA TTM = -30.0m USD
Long Term Debt = 79.3m USD (from capitalLeaseObligations, last quarter)
Short Term Debt = 3.59m USD (from shortTermDebt, last fiscal year)
Debt = 72.6m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -556.0m USD (from netDebt column, last quarter)
Enterprise Value = 7.05b USD (8.43b + Debt 72.6m - CCE 1.45b)
Interest Coverage Ratio = -0.78 (Ebit TTM -45.2m / Interest Expense TTM -58.0m)
FCF Yield = 4.39% (FCF TTM 309.6m / Enterprise Value 7.05b)
FCF Margin = 20.69% (FCF TTM 309.6m / Revenue TTM 1.50b)
Net Margin = 1.35% (Net Income TTM 20.2m / Revenue TTM 1.50b)
Gross Margin = 82.86% ((Revenue TTM 1.50b - Cost of Revenue TTM 256.5m) / Revenue TTM)
Gross Margin QoQ = 82.20% (prev 82.09%)
Tobins Q-Ratio = 2.72 (Enterprise Value 7.05b / Total Assets 2.59b)
Interest Expense / Debt = 24.98% (Interest Expense 18.1m / Debt 72.6m)
Taxrate = 52.39% (1.74m / 3.33m)
NOPAT = -21.5m (EBIT -45.2m * (1 - 52.39%)) [loss with tax shield]
Current Ratio = 2.75 (Total Current Assets 2.03b / Total Current Liabilities 738.4m)
Debt / Equity = 0.04 (Debt 72.6m / totalStockholderEquity, last quarter 1.67b)
Debt / EBITDA = 18.53 (negative EBITDA) (Net Debt -556.0m / EBITDA -30.0m)
Debt / FCF = -1.80 (Net Debt -556.0m / FCF TTM 309.6m)
Total Stockholder Equity = 1.74b (last 4 quarters mean from totalStockholderEquity)
RoA = 0.78% (Net Income 20.2m / Total Assets 2.59b)
RoE = 1.16% (Net Income TTM 20.2m / Total Stockholder Equity 1.74b)
RoCE = -2.49% (EBIT -45.2m / Capital Employed (Equity 1.74b + L.T.Debt 79.3m))
RoIC = -1.24% (negative operating profit) (NOPAT -21.5m / Invested Capital 1.74b)
WACC = 9.98% (E(8.43b)/V(8.50b) * Re(9.96%) + D(72.6m)/V(8.50b) * Rd(24.98%) * (1-Tc(0.52)))
Discount Rate = 9.96% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -2.15%
[DCF Debug] Terminal Value 70.98% ; FCFE base≈316.5m ; Y1≈306.2m ; Y5≈303.9m
Fair Price DCF = 8.69 (DCF Value 3.94b / Shares Outstanding 453.6m; 5y FCF grow -4.47% → 3.0% )
EPS Correlation: -16.03 | EPS CAGR: -61.74% | SUE: -4.0 | # QB: 0
Revenue Correlation: 73.86 | Revenue CAGR: 12.33% | SUE: 1.59 | # QB: 2

Additional Sources for PATH Stock

News: Wall Street Journal | Benzinga | Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle